FF30 Table-top Filling and Capping Machine - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

FF30 Table-top Filling and Capping Machine


The Flexicon FF30 semi-automatic filling and capping machine is ideal for flexible small scale production. The speed of the FF30 can be adjusted to match the working speed of the operator and liquids can be filled in volumes from 0.1ml to 100ml with +/-0.5% accuracy.

Offering a capacity up to 1200 bottles per hour (depending on filling volume and operator), and able to handle bottles between 12mm and 50mm in diameter, key application areas for the FF30 include the diagnostic industry, hospital pharmacies, R&D departments, essential oil manufacturers, cosmetics producers and general subcontract filling/finish companies.

The FF30 ensures clean production without risk of cross-contamination; a consistent cap torque prevents any leakage of liquid, while a bottle/cap change takes a maximum of five minutes, helping improving uptime and productivity.

The machine’s small footprint makes it ideal for use in laminar air flow units or bio-safety cabinets.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here